The partnership emphasizes supply chain redundancy, a core component of Amsino’s strategy to prevent disruptions for healthcare providers. By leveraging multiple manufacturing sites, the company intends to ensure consistent product availability for hospitals navigating fluctuating demand. The enteral syringe portfolio is designed to meet rigorous standards for medication delivery across diverse clinical environments.

Jeff Reid, Amsino's President of North America, noted that the agreement reinforces the company's commitment to providing reliable, high-quality medical devices alongside responsive support. This deal marks a continuation of the firm's long-term collaboration with Vizient, as Amsino continues to invest in vertically integrated manufacturing and expanded North American infrastructure to support its growing client base.